Rhythm Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Rhythm Pharmaceuticals Inc
TickerRYTM
CIK #0001649904
CUSIP76243J105
SectorLife Sciences - Pharmaceutical Preparations
Address500 Boylston Street 11th Floor, Boston, MA 02116
Source [EDGAR]
CIK Filing 2011 - 2025
[0001649904] 10-K
[0001649904] 10-Q
[0001649904] 3
[0001649904] 4
[0001649904] 5
[0001649904] 8-K
[0001649904] D
[0001649904] SC 13D
[0001649904] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Perceptive Advisors LLC Rhythm Pharmaceuticals Inc [2024-11-14] 81948.6
Perceptive Advisors LLC Rhythm Pharmaceuticals Inc [2024-03-20] 81945.4
Vanguard Group Inc Rhythm Pharmaceuticals Inc [2024-02-13] 5.46
Perceptive Advisors LLC Rhythm Pharmaceuticals Inc [2024-02-12] 81945.5
State Street Corp Rhythm Pharmaceuticals Inc [2023-02-03] 5.64
BlackRock Inc Rhythm Pharmaceuticals Inc [2023-02-03] 6.6
BlackRock Inc Rhythm Pharmaceuticals Inc [2022-07-08] 2.3
Goldman Sachs Group Inc Rhythm Pharmaceuticals Inc [2022-01-24] 6.1
Federated Hermes Inc Rhythm Pharmaceuticals Inc [2021-02-12] 5.92
BlackRock Inc Rhythm Pharmaceuticals Inc [2020-02-07] 5.8
Wellington Management Group LLP Rhythm Pharmaceuticals Inc [2020-01-28] 7.56
Flynn James E Rhythm Pharmaceuticals Inc [2019-08-19] 4.22
RA Capital Management LLC Rhythm Pharmaceuticals Inc [2019-02-14] 5.7
Janus Henderson Group PLC Rhythm Pharmaceuticals Inc [2019-02-12] 0.5
Third Rock Ventures LP Rhythm Pharmaceuticals Inc [2018-02-13] 14.6
Baker Bros Advisors LP Rhythm Pharmaceuticals Inc [2018-02-13] 7.5
MPM BioVentures V LP Rhythm Pharmaceuticals Inc [2017-10-24] 0.5
OrbiMed Advisors LLC Rhythm Pharmaceuticals Inc [2017-10-20] 10.7
Pfizer Inc Rhythm Pharmaceuticals Inc [2017-10-18] 9.0
New Enterprise Associates 13 LP Rhythm Pharmaceuticals Inc [2017-10-13] 18.8
Flynn James E Rhythm Pharmaceuticals Inc [2017-10-10] 1.8
Form 3/4/5 Filer 2011 - 2025
Rhythm Pharmaceuticals Inc
German Christopher Paul
Smith Hunter C
Shulman Joseph
Cramer Pamela J.
Garfield Alastair
Arbuckle Stuart A
Jean Christophe
Good Jennifer L
Bedrosian Camille L
Mathers Edward T
McGirr David W J
Tetrault Lynn A
Meeker David P
Mazabraud Yann
Lee Jennifer Kayden
Roberts William T.
Manning Linda Shapiro
Foley Todd
Stewart Murray
Kelner Simon
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
Shah Rajeev M.
Desikan Nithya
Gottesdiener Keith Michael
Van der Ploeg Leonardus H.T.
Starr Kevin P
Third Rock Ventures GP, L.P.
TRV GP LLC
Levin Mark J
Third Rock Ventures LP
Tepper Robert I
Exter Neil
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Fiedorek Fred T.
MPM BioVentures V LLC
MPM BioVentures V LP
MPM Asset Management Investors BV5 LLC
Gadicke Ansbert
Evnin Luke
MPM BioVentures V GP LLC
Hadley Harbor Master Investors (Cayman) L.P.
Silverstein Jonathan
Isaly Samuel D
Barris Peter J
Baskett Forest
Kerins Patrick J
Mott David M
Sandell Scott D
Viswanathan Ravi
NEA 13 GP, Ltd
New Enterprise Associates 13 LP
NEA Partners 13, Limited Partnership
Barrett M James
Deerfield Mgmt L.P.
Flynn James E
Deerfield Mgmt III, L.P.
Deerfield Special Situations Fund, L.P.
Deerfield Management Company LP
Deerfield Private Design Fund III, L.P.
Ipsen, S.A.
Pfizer Inc
Baker Bros Advisors LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Baker Julian
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 6,077,015 6,267,538
Baker Bros Advisors LP [2025-06-30] SOLE 5,604,483 5,604,483
RA Capital Management LP [2025-06-30] SOLE 5,561,359 5,561,359
PRIMECAP Management Co/CA/ [2025-06-30] SOLE 4,878,037 4,878,037
Vanguard Group Inc [2025-06-30] SOLE 0 3,473,252
NEA Management Company LLC [2025-06-30] DFND 2,909,956 2,909,956
Perceptive Advisors LLC [2025-06-30] SOLE 2,418,299 2,418,299
FMR LLC [2025-06-30] DFND 1,949,000 1,953,441
State Street Corp [2025-06-30] DFND 1,738,926 1,907,601
Goldman Sachs Group Inc [2025-06-30] DFND 1,731,589 1,733,722
Federated Hermes Inc [2025-06-30] DFND 1,686,494 1,686,494
Westfield Capital Management Co LP [2025-06-30] SOLE 1,155,499 1,629,468
Janus Henderson Group PLC [2025-06-30] DFND 0 1,411,902
Geode Capital Management LLC [2025-06-30] DFND 1,311,253 1,311,253
Driehaus Capital Management LLC [2025-06-30] SOLE 999,610 1,269,952
Polar Capital Holdings Plc [2025-06-30] DFND 1,250,870 1,250,870
Checkpoint Capital LP [2025-06-30] SOLE 1,060,000 1,060,000
Rock Springs Capital Management LP [2025-06-30] SOLE 861,153 861,153
Alkeon Capital Management LLC [2025-06-30] SOLE 847,415 847,415
Sofinnova Investments Inc [2025-06-30] SOLE 811,010 811,010
JPMorgan Chase & Co [2025-06-30] DFND 668,147 783,559
Loomis Sayles & Co L P [2025-06-30] DFND 581,046 591,454
Franklin Resources Inc [2025-06-30] DFND 529,238 543,802
Hood River Capital Management LLC [2025-06-30] SOLE 526,944 543,688
Morgan Stanley [2025-06-30] DFND 450,420 524,480
Woodline Partners LP [2025-06-30] SOLE 514,381 514,381
Northern Trust Corp [2025-06-30] DFND 500,830 501,305
Opaleye Management Inc [2025-06-30] SOLE 475,000 475,000
Charles Schwab Investment Management Inc [2025-06-30] SOLE 461,438 461,438
Pictet Asset Management Holding SA [2025-06-30] SOLE 385,237 416,115
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com